<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>nebivolol</title><link>http://www.unboundmedicine.com/medline/ebm/research/nebivolol</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Nebivolol has Protective Effect Against Endothelial and Ileal Dysfunction due to I/R.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922953/full_citation/Nebivolol_has_Protective_Effect_Against_Endothelial_and_Ileal_Dysfunction_due_to_I/R_</link><description>Soydan G, Cekiç EG, Tuncer M <br/><span class="title">Nebivolol has Protective Effect Against Endothelial and Ileal Dysfunction due to I/R. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Journal of surgical research">J Surg Res 2009 Jul 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922953/abstract/Nebivolol_has_Protective_Effect_Against_Endothelial_and_Ileal_Dysfunction_due_to_I/R_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922953/full_citation/Nebivolol_has_Protective_Effect_Against_Endothelial_and_Ileal_Dysfunction_due_to_I/R_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19922953/Nebivolol_has_Protective_Effect_Against_Endothelial_and_Ileal_Dysfunction_due_to_I/R_">Find Related Articles</a> </description></item><item><title>Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. The QoLaN study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19919391/full_citation/Quality_of_life_and_efficacy_of_nebivolol_in_an_open_label_study_in_hypertensive_patients__The_QoLaN_study_</link><description>Hermans MP, De Coster O, Seidel L, et al. <br/><span class="title">Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. The QoLaN study. [JOURNAL ARTICLE]</span><br/><span class="source" title="Blood pressure">Blood Press 2009 Oct 29; 18(S1):5-14.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19919391/abstract/Quality_of_life_and_efficacy_of_nebivolol_in_an_open_label_study_in_hypertensive_patients__The_QoLaN_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19919391/full_citation/Quality_of_life_and_efficacy_of_nebivolol_in_an_open_label_study_in_hypertensive_patients__The_QoLaN_study_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19919391/Quality_of_life_and_efficacy_of_nebivolol_in_an_open_label_study_in_hypertensive_patients__The_QoLaN_study_">Find Related Articles</a> </description></item><item><title>Validation and application of high-performance liquid chromatographic and spectrophotometric methods for simultaneous estimation of nebivolol and hydrochlorothiazide: a novel approach to multivariate calibrations by R-Software Environment.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19916373/full_citation/Validation_and_application_of_high_performance_liquid_chromatographic_and_spectrophotometric_methods_for_simultaneous_estimation_of_nebivolol_and_hydrochlorothiazide:_a_novel_approach_to_multivariate_calibrations_by_R_Software_Environment_</link><description>Gowda N, Panghal S, Vipul K, et al. <br/><span class="title">Validation and application of high-performance liquid chromatographic and spectrophotometric methods for simultaneous estimation of nebivolol and hydrochlorothiazide: a novel approach to multivariate calibrations by R-Software Environment. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Journal of AOAC International">J AOAC Int 2009 Sep-Oct; 92(5):1356-65.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19916373/abstract/Validation_and_application_of_high_performance_liquid_chromatographic_and_spectrophotometric_methods_for_simultaneous_estimation_of_nebivolol_and_hydrochlorothiazide:_a_novel_approach_to_multivariate_calibrations_by_R_Software_Environment_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19916373/full_citation/Validation_and_application_of_high_performance_liquid_chromatographic_and_spectrophotometric_methods_for_simultaneous_estimation_of_nebivolol_and_hydrochlorothiazide:_a_novel_approach_to_multivariate_calibrations_by_R_Software_Environment_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19916373/Validation_and_application_of_high_performance_liquid_chromatographic_and_spectrophotometric_methods_for_simultaneous_estimation_of_nebivolol_and_hydrochlorothiazide:_a_novel_approach_to_multivariate_calibrations_by_R_Software_Environment_">Find Related Articles</a> </description></item><item><title>Neither K + Channels Nor PI3K/Akt Mediates the Vasodilative Effect of Nebivolol on Different Types of Rat Arteries.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19903983/full_citation/Neither_K_+_Channels_Nor_PI3K/Akt_Mediates_the_Vasodilative_Effect_of_Nebivolol_on_Different_Types_of_Rat_Arteries_</link><description>Wang Y, Zhang M, Liu Y, et al. <br/><span class="title">Neither K + Channels Nor PI3K/Akt Mediates the Vasodilative Effect of Nebivolol on Different Types of Rat Arteries. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of cardiovascular pharmacology and therapeutics">J Cardiovasc Pharmacol Ther 2009 Dec; 14(4):332-338.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19903983/abstract/Neither_K_+_Channels_Nor_PI3K/Akt_Mediates_the_Vasodilative_Effect_of_Nebivolol_on_Different_Types_of_Rat_Arteries_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19903983/full_citation/Neither_K_+_Channels_Nor_PI3K/Akt_Mediates_the_Vasodilative_Effect_of_Nebivolol_on_Different_Types_of_Rat_Arteries_">Full Citation</a></description></item><item><title>Nebivolol in the treatment of metabolic syndrome: Making the fat more brownish.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19892472/full_citation/Nebivolol_in_the_treatment_of_metabolic_syndrome:_Making_the_fat_more_brownish_</link><description>Solak Y, Atalay H <br/><span class="title">Nebivolol in the treatment of metabolic syndrome: Making the fat more brownish. [LETTER]</span><br/><span class="source" title="Medical hypotheses">Med Hypotheses 2009 Nov 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19892472/full_citation/Nebivolol_in_the_treatment_of_metabolic_syndrome:_Making_the_fat_more_brownish_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0306-9877(09)00686-0">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19892472/Nebivolol_in_the_treatment_of_metabolic_syndrome:_Making_the_fat_more_brownish_">Find Related Articles</a> </description></item><item><title>Reduced Intimal Hyperplasia in Rabbits via Medical Therapy after Carotid Venous Bypass.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19876413/full_citation/Reduced_Intimal_Hyperplasia_in_Rabbits_via_Medical_Therapy_after_Carotid_Venous_Bypass_</link><description>Yucel S, Bahcivan M, Gol MK, et al. <br/><span class="title">Reduced Intimal Hyperplasia in Rabbits via Medical Therapy after Carotid Venous Bypass. [Journal Article]</span><br/><span class="source" title="Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital">Tex Heart Inst J 2009; 36(5):387-92.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19876413/abstract/Reduced_Intimal_Hyperplasia_in_Rabbits_via_Medical_Therapy_after_Carotid_Venous_Bypass_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19876413/full_citation/Reduced_Intimal_Hyperplasia_in_Rabbits_via_Medical_Therapy_after_Carotid_Venous_Bypass_">Full Citation</a></description></item><item><title>Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: A retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19843484/full_citation/Efficacy_and_tolerability_of_nebivolol_monotherapy_by_baseline_systolic_blood_pressure:_A_retrospective_analysis_of_pooled_data_from_two_multicenter_12_week_randomized_double_blind_placebo_controlled_parallel_group_dose_ranging_studies_in_patients_with_mild_to_moderate_essential_hypertension_</link><description>Germino FW <br/><span class="title">Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: A retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension. [Journal Article]</span><br/><span class="source" title="Clinical therapeutics">Clin Ther 2009 Sep; 31(9):1946-56.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19843484/abstract/Efficacy_and_tolerability_of_nebivolol_monotherapy_by_baseline_systolic_blood_pressure:_A_retrospective_analysis_of_pooled_data_from_two_multicenter_12_week_randomized_double_blind_placebo_controlled_parallel_group_dose_ranging_studies_in_patients_with_mild_to_moderate_essential_hypertension_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19843484/full_citation/Efficacy_and_tolerability_of_nebivolol_monotherapy_by_baseline_systolic_blood_pressure:_A_retrospective_analysis_of_pooled_data_from_two_multicenter_12_week_randomized_double_blind_placebo_controlled_parallel_group_dose_ranging_studies_in_patients_with_mild_to_moderate_essential_hypertension_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19843484/Efficacy_and_tolerability_of_nebivolol_monotherapy_by_baseline_systolic_blood_pressure:_A_retrospective_analysis_of_pooled_data_from_two_multicenter_12_week_randomized_double_blind_placebo_controlled_parallel_group_dose_ranging_studies_in_patients_with_mild_to_moderate_essential_hypertension_">Find Related Articles</a> </description></item><item><title>Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19819787/full_citation/Nebivolol_therapy_improves_endothelial_function_and_increases_exercise_tolerance_in_patients_with_cardiac_syndrome_X_</link><description>Sen N, Tavil Y, Erdamar H, et al. <br/><span class="title">Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X. [JOURNAL ARTICLE]</span><br/><span class="source" title="Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology">Anadolu Kardiyol Derg 2009 Oct; 9(5):371-379.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19819787/abstract/Nebivolol_therapy_improves_endothelial_function_and_increases_exercise_tolerance_in_patients_with_cardiac_syndrome_X_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19819787/full_citation/Nebivolol_therapy_improves_endothelial_function_and_increases_exercise_tolerance_in_patients_with_cardiac_syndrome_X_">Full Citation</a></description></item><item><title>Nebivolol: the somewhat-different beta-adrenergic receptor blocker.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19815121/full_citation/Nebivolol:_the_somewhat_different_beta_adrenergic_receptor_blocker_</link><description>Münzel T, Gori T <br/><span class="title">Nebivolol: the somewhat-different beta-adrenergic receptor blocker. [Journal Article, Review]</span><br/><span class="source" title="Journal of the American College of Cardiology">J Am Coll Cardiol 2009 Oct 13; 54(16):1491-9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19815121/abstract/Nebivolol:_the_somewhat_different_beta_adrenergic_receptor_blocker_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19815121/full_citation/Nebivolol:_the_somewhat_different_beta_adrenergic_receptor_blocker_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(09)02431-0">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19815121/Nebivolol:_the_somewhat_different_beta_adrenergic_receptor_blocker_">Find Related Articles</a> </description></item><item><title>Efficacy of nebivolol on flow-mediated dilation in patients with slow coronary flow.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19809204/full_citation/Efficacy_of_nebivolol_on_flow_mediated_dilation_in_patients_with_slow_coronary_flow_</link><description>Albayrak S, Ordu S, Yuksel H, et al. <br/><span class="title">Efficacy of nebivolol on flow-mediated dilation in patients with slow coronary flow. [Journal Article]</span><br/><span class="source" title="International heart journal">Int Heart J 2009 Sep; 50(5):545-53.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19809204/abstract/Efficacy_of_nebivolol_on_flow_mediated_dilation_in_patients_with_slow_coronary_flow_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19809204/full_citation/Efficacy_of_nebivolol_on_flow_mediated_dilation_in_patients_with_slow_coronary_flow_">Full Citation</a></description></item></channel></rss>